Target type: cellularcomponent
Complex that possesses guanylate cyclase activity and is not bound to a membrane. [GOC:mah]
The guanylate cyclase complex, soluble, is a multi-protein assembly that catalyzes the conversion of GTP to cyclic GMP (cGMP) in the cytosol. This complex is typically found in a soluble form, meaning it is not associated with membranes. The exact composition of the complex can vary depending on the cell type and species, but it often includes a guanylate cyclase catalytic subunit, which is responsible for the enzymatic activity, and a variety of regulatory proteins that control the activity of the complex. These regulatory proteins can include proteins that bind to calcium, calmodulin, or other signaling molecules. The soluble guanylate cyclase complex plays an important role in a wide range of cellular processes, including signal transduction, gene expression, and cell growth. It is particularly important in the regulation of smooth muscle relaxation, and it is also involved in the response to nitric oxide (NO). The soluble guanylate cyclase complex is activated by NO, which binds to the heme group of the catalytic subunit and stimulates its activity. This activation leads to an increase in intracellular cGMP levels, which can then activate downstream signaling pathways. In summary, the soluble guanylate cyclase complex is a complex and dynamic signaling molecule that plays an important role in a variety of cellular processes.'
"
Protein | Definition | Taxonomy |
---|---|---|
Guanylate cyclase soluble subunit alpha-2 | A guanylate cyclase soluble subunit alpha-2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P33402] | Homo sapiens (human) |
Guanylate cyclase soluble subunit beta-2 | A guanylate cyclase soluble subunit beta-2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O75343] | Homo sapiens (human) |
Guanylate cyclase soluble subunit beta-1 | A guanylate cyclase soluble subunit beta-1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q02153] | Homo sapiens (human) |
Guanylate cyclase soluble subunit alpha-1 | A guanylate cyclase soluble subunit alpha-1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q02108] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
gemfibrozil | aromatic ether | antilipemic drug | |
6-anilino-5,8-quinolinedione | 6-anilino-5,8-quinolinedione : A quinolone that is quinoline-5,8-dione in which the hydrogen at position 6 is replaced by an anilino group. 6-anilino-5,8-quinolinedione: structure given in first source; SRS-A & guanylate cyclase antagonist | aminoquinoline; aromatic amine; p-quinones; quinolone | antineoplastic agent; EC 4.6.1.2 (guanylate cyclase) inhibitor |
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation. | aromatic primary alcohol; furans; indazoles | antineoplastic agent; apoptosis inducer; platelet aggregation inhibitor; soluble guanylate cyclase activator; vasodilator agent |
benzydamine | benzydamine : A member of the class of indazoles carrying benzyl and 3-(dimethylamino)propyl groups at positions 1 and 3 respectively. A locally-acting nonsteroidal anti-inflammatory drug that also exhibits local anaesthetic and analgesic properties. Benzydamine: A benzyl-indazole having analgesic, antipyretic, and anti-inflammatory effects. It is used to reduce post-surgical and post-traumatic pain and edema and to promote healing. It is also used topically in treatment of RHEUMATIC DISEASES and INFLAMMATION of the mouth and throat. | aromatic ether; indazoles; tertiary amino compound | analgesic; central nervous system stimulant; hallucinogen; local anaesthetic; non-steroidal anti-inflammatory drug |
bay 41-8543 | BAY 41-8543: structure in first source | pyrazolopyridine |